Page Of Honor

Medical Leaders & Advocates

At the Amyloidosis Army, we believe awareness begins with education—and education starts with experts who care deeply about patients. Since 2024, leading physicians, researchers, and healthcare professionals have generously shared their knowledge at our events, helping patients, families, and communities better understand amyloidosis and the critical importance of early diagnosis.

These medical leaders and advocates are more than just speakers—they are partners in our mission. By lending their expertise, they empower patients to ask the right questions, pursue the right tests, and access the treatments that can save lives. Their voices amplify our efforts to shine a light on this “rare” but too-often overlooked disease.

We are deeply grateful to every doctor and healthcare professional who stands with us. Their dedication fuels progress, inspires hope, and makes a lasting difference for the amyloidosis community.

👉 Together, we’re turning awareness into action.

Dr. Sperry – Kansas City

Dr. Sperry has been a dedicated partner to the Amyloidosis Army, sharing his expertise and passion for patient care at our Kansas City events. His commitment to educating patients, families, and healthcare providers has helped countless people better understand the importance of early testing and treatment for amyloidosis. By bringing clarity to a complex disease, Dr. Sperry continues to make a powerful impact in the community and inspire hope for those living with amyloidosis.

Dr. V. Savas – Cardiovascular Disease & Internal Medicine, Michigan

Dr. V. Savas is a dedicated physician specializing in cardiovascular disease and internal medicine, bringing critical expertise to the fight against amyloidosis. Through his work and contributions at Amyloidosis Army events in Michigan, Dr. Savas has helped patients and families better understand how amyloidosis affects the heart and why early detection is essential. His commitment to patient education and community awareness continues to drive progress and hope, ensuring more people receive the care they need before it’s too late.

Dr. R. Angel Garcia – Mid America Heart Institute, Saint Luke’s Hospital of Kansas

Dr. R. Angel Garcia of the Mid America Heart Institute at Saint Luke’s Hospital is a leading voice in advancing the understanding and treatment of amyloidosis. His expertise in cardiology and his dedication to patient care have brought invaluable insights to Amyloidosis Army events. Dr. Garcia’s work emphasizes the importance of early recognition of cardiac amyloidosis and the role of innovative treatments in improving outcomes. We are honored to recognize Dr. Garcia for his commitment to education, advocacy, and the patients and families who depend on timely, accurate care.

Angela A. Moss, MBA, RN, APN-C – Mid State Black Nurses Association of New Jersey

Angela A. Moss, MBA, RN, APN-C, of the Mid State Black Nurses Association of New Jersey, is a dedicated healthcare leader and advocate for equity in patient care. Her work focuses on empowering communities with education, resources, and support to improve health outcomes, particularly in underserved populations where amyloidosis often goes undiagnosed. By partnering with the Amyloidosis Army, Angela brings both clinical expertise and community-focused leadership to our mission, ensuring patients and families have the knowledge and tools they need to advocate for early detection and treatment. We are honored to recognize her commitment to awareness, advocacy, and advancing healthcare equity.

Dr. Vasvi Singh – Director, Cardiac Amyloidosis Program, HCA Midwest Health

Dr. Vasvi Singh serves as the Director of the Cardiac Amyloidosis Program at HCA Midwest Health, where he leads efforts to improve diagnosis and treatment for patients with cardiac involvement. His expertise and leadership have been instrumental in bringing cutting-edge knowledge to the Amyloidosis Army community. By speaking at our events, Dr. Singh has helped raise awareness about the critical role of the heart in amyloidosis and the importance of early, specialized care. We are proud to honor Dr. Singh for his dedication to advancing patient outcomes and his commitment to education, advocacy, and hope.

Dr. Zubair Shah – KU Med, Kansas City, Kansas

Dr. Zubair Shah of KU Medical Center has been an invaluable voice in the fight against amyloidosis. Through his work and his presentations at Amyloidosis Army events, Dr. Shah has helped patients, caregivers, and providers gain a deeper understanding of this complex disease. His dedication to advancing awareness and improving patient outcomes makes him a trusted leader in the Kansas City community and beyond. We are grateful for his partnership and his commitment to ensuring more patients receive timely diagnosis and care.

Dr. J. Ampadu – Cardiology, Prisma Health Advanced Heart Health Center

Dr. J. Ampadu of the Prisma Health Advanced Heart Health Center is a respected cardiologist whose expertise has greatly contributed to advancing awareness and treatment of amyloidosis. By sharing his knowledge at Amyloidosis Army events, Dr. Ampadu has helped patients, families, and providers understand the critical role the heart plays in amyloidosis and why early detection is essential. His commitment to education, compassionate care, and community advocacy continues to make a lasting difference for those affected by this rare disease. We are proud to honor Dr. Ampadu for his dedication and leadership in the fight against amyloidosis.

Dr. R. Bullock-Palmer – Director, Women’s Heart Center, Deborah Heart and Lung Center, New Jersey

Dr. R. Bullock-Palmer, Director of the Women’s Heart Center at Deborah Heart and Lung Center in New Jersey, is a passionate advocate for women’s cardiovascular health and the early recognition of amyloidosis. Her leadership in cardiology and her dedication to addressing disparities in care have made her an invaluable partner to the Amyloidosis Army. By sharing her expertise at our events, Dr. Bullock-Palmer helps patients and families better understand the unique challenges of cardiac amyloidosis and the importance of timely diagnosis. We are proud to honor her commitment to advancing awareness, improving outcomes, and giving a stronger voice to women in heart health.